News | January 07, 2022
Lupin launches Molnulup to treat Covid-19
The drug is priced at Rs 2000 for a course of 40 tablets
The drug is priced at Rs 2000 for a course of 40 tablets
The brand is now available pan-India through their distribution partner
ASC10 is an oral direct-acting antiviral drug candidate targeting RNA dependent RNA polymerase (RdRp) to treat SARS-CoV-2 infection
The Subject Expert Committee (SEC), on Covid-19 of the Central Drugs Standard Control Organisation (CDSCO) on Monday recommended granting permission to manufacture and market anti-Covid pill molnupiravir for restricted emergency use
DCGI approved the drug based on the review of clinical data
The drug will be marketed under the brand name Molnaflu
Flattish volume growth and subdued new launches were key factors for last month
The revolutionary new nano coating is easy to apply and rejects liquid-based contagions like COVID-19/SARS-CoV-2 and variants, influenzas, and rhinoviruses and is available via ready-to-use sprays or pre-treated air filters
The data has been shared with the U.S.FDA as part of an ongoing rolling submission for Emergency Use Authorisation
The U.S. FDA advisory committee voted 13-10 in favour of the oral antiviral medicine
Subscribe To Our Newsletter & Stay Updated
